Kura Oncology (KURA) Change in Acquisitions & Divestments (2016 - 2026)

Kura Oncology (KURA) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $147.5 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $147.5 million, down 11.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $735.0 million (up 17.47% YoY), and the FY2025 annual result was $755.1 million, up 35.34% from the prior year.
• Change in Acquisitions & Divestments declined to $147.5 million in Q1 2026 per KURA's latest filing, from $177.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $235.0 million in Q3 2025 and troughed at $26.5 million in Q1 2022.
• A 5-year average of $128.8 million and a median of $129.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 35.01% in 2022, then jumped 220.91% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $58.8 million in 2022, then jumped by 141.26% to $141.9 million in 2023, then increased by 2.89% to $146.0 million in 2024, then grew by 21.58% to $177.5 million in 2025, then decreased by 16.9% to $147.5 million in 2026.
• Business Quant data shows KURA's Change in Acquisitions & Divestments at $147.5 million in Q1 2026, $177.5 million in Q4 2025, and $235.0 million in Q3 2025.